You're viewing our updated article page. If you need more time to adjust, you can return to the old layout.

CORRECTION article

Front. Pharmacol., 01 June 2023

Sec. Translational Pharmacology

Volume 14 - 2023 | https://doi.org/10.3389/fphar.2023.1217008

Corrigendum: Pharmacokinetics and bioequivalence study of esomeprazole magnesium enteric-coated tablets 20 mg in healthy Chinese subjects under fasting and fed conditions

  • Wuxi People’s Hospital Affiliated to Nanjing Medical University, Wuxi, China

Article metrics

View details

1,3k

Views

597

Downloads

In the published article, there was an error in the author list. The corrected author list appears below.

“Ying Ding†, Nannan Chu†, Linling Que, Kai Huang, Yuanxing Chen, Wei Qin, Zhenzhong Qian, Yunfei Shi, Zhen Xu, and Qing He*”

A correction has been made to Author contributions. This sentence previously stated:

“YD and QH designed the study. NC, YD, LQ, KH, YC, WQ, ZQ, YS, and ZX performed the clinical study. NC wrote and revised the manuscript.”

The corrected sentence appears below:

“QH and YD designed the study. YD, LQ, KH, YC, WQ, ZQ, YS, and ZX performed the clinical study. NC wrote and revised the manuscript.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

esomeprazole magnesium enteric-coated tablet, bioequivalence, pharmacokinetics, safety, healthy Chinese subjects

Citation

Ding Y, Chu N, Que L, Huang K, Chen Y, Qin W, Qian Z, Shi Y, Xu Z and He Q (2023) Corrigendum: Pharmacokinetics and bioequivalence study of esomeprazole magnesium enteric-coated tablets 20 mg in healthy Chinese subjects under fasting and fed conditions. Front. Pharmacol. 14:1217008. doi: 10.3389/fphar.2023.1217008

Received

04 May 2023

Accepted

18 May 2023

Published

01 June 2023

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

14 - 2023

Updates

Copyright

*Correspondence: Qing He,

†These authors have contributed equally to this work and share first authorship

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics